We evaluated the effect of IGF-II on the toxicity induced by CORT and MPP+ treatment in TH levels, and we found that IGF-II maintained the TH expression, which agreed with our previous results in drug-induced cellular PD [24]. Here, IGF2 is linked to Parkinson disease.